Clinical Trial Update: NovoLet® Surveillance Study on Using Human Insulin System in Indonesia

View source ↗

Summary

This document reports the completion of a NovoLet surveillance trial in Indonesia evaluating the use of NovoLet (insulin human) for diabetes management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoLet (insulin human)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED